A detailed history of Ares Financial Consulting, LLC transactions in Insulet Corp stock. As of the latest transaction made, Ares Financial Consulting, LLC holds 23 shares of PODD stock, worth $7,652. This represents 0.01% of its overall portfolio holdings.

Number of Shares
23
Holding current value
$7,652
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 29, 2026

BUY
$305.98 - $336.84 $7,037 - $7,747
23 New
23 $6.54 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $23.1B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Ares Financial Consulting, LLC Portfolio

Follow Ares Financial Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ares Financial Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ares Financial Consulting, LLC with notifications on news.